Day: November 18, 2016

Update on RISUG

A much-anticipated update on the development of RISUG (reversible inhibition of sperm under guidance) was provided by journalist Sohini Chattopadhyay in a recent article in The Wire.

Read More »
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today